Trade Summary

Yesterday, Patel Dinesh V Ph D, serving as Pres, CEO at Protagonist Therapeutics, Inc (PTGX), sold 75,000 shares at $100.12 per share, for a total transaction value of $7,509,000.00. Following this transaction, Patel Dinesh V Ph D now holds 523,478 shares of PTGX.

This sale represents a 13.00% decrease in Patel Dinesh V Ph D's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 12, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 12, 2026, meaning the disclosure happened on the same day as the trade.

Protagonist Therapeutics, Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.